General Research InterestClinical Pharmacy
Research DescriptionLarry J. Schaaf, PhD is Director of the Clinical Treatment Unit (CTU) at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Dr. Schaaf has extensive experience in pharmacokinetics and early clinical trials and has played a key role in the development and clinical application of a number of widely used anti-cancer drugs, including irinotecan, exemestane, and epirubicin. Dr. Schaaf also manages the Clinical Trials Processing Laboratory (CTPL) which is responsible of procurement, processing, storage and shipment of the majority of correlative science specimens collected as part of phase I trials.
Transinstitutional WorkDr. Schaaf collaborates with a number of investigators in designing the pharmacokinetic and pharmacodynamic components of clinical trials. As Director of the Clinical Trials Processing Laboratory, he insures that correlative research specimens collected at OSU but analyzed at outside institutions are properly processed, stored and shipped